Health Wildcatters graduate VenoStent will line its pockets a bit to continue developing an external wrap to help reduce dialysis access site failures by reinforcing the veins.
The company has been awarded a National Science Foundation Small Business Technology Transfer grant. The $224,500 award will go toward research and development work on—I’ll quote from the news release here—“the biomechanics and hemodynamic effects that an external stent can have on venous access site geometries.”
VenoStent is the product of two recent Vanderbilt University graduate program alums, Tim Boire (CEO) and Geoffrey Lucks (CFO).
The company was a graduate of the 2017 Health Wildcatters Accelerator.